Our synthetic immunology approach empowers the weakened immune system of cancer patients, offering allogeneic, agnostic and durable T cells.
Mentions in press and media 1
| Date | Title | Description |
| 07.12.2023 | Nine medical innovations with disruptive potential: Start-ups presented their ideas at the “Munich Demo Day” of the BioTech Bootcamp of BioM and SmiLe | As part of this year's BioTech Bootcamp of BioM Biotech Cluster Development GmbH and the life science business incubator „SmiLe Incubator“ from Lund, Sweden, the international, eight-week training program for prospective founders and young ... |